Introducing cichorium pumilum as a potential therapeutical agent against drug-induced benign breast tumor in rats

33Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cichorium Pumilum (chicory) is could be a promising cancer treatment in which a photosensitizing drug concentrates in benign tumor cells and activated by quanta at certain wavelength. Such activated extracts could lead to cell death and tumor ablation. Previous studies have shown that Cichorium Pumilum (chicory) contains photosensitive compounds such as cichoriin, anthocyanins, lactucin, and Lactucopicrin. In the present study, the protective effect of sun light-activated Cichorium against the dimethylbenz[a]anthracene (DMBA) induced benign breast tumors to female Sprague-Dawley rats was investigated. Chicory's extract has significantly increase P.carbonyl (PC) and malondialdehyde (MDA) and decreases the hepatic levels of total antioxidant capacity (TAC) and superoxide dismutase (SOD) in benign breast tumors-induced group compared to control. It also significantly decrease the number of estrogen receptors ER-positive cells in tumor masses. These results suggest that chicory extracts could be used as herbal photosensitizing agent in treating benign breast tumor in rats. © 2012 Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Al-Akhras, M. A. H., Aljarrah, K., Al-Khateeb, H., Jaradat, A., Al-Omari, A., Al-Nasser, A., … Daoud, S. (2012). Introducing cichorium pumilum as a potential therapeutical agent against drug-induced benign breast tumor in rats. Electromagnetic Biology and Medicine, 31(4), 299–309. https://doi.org/10.3109/15368378.2012.662193

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free